-
Mashup Score: 0Treating EGFR Mutant NSCLC in Brazil | IASLC - 10 month(s) ago
This episode of Lung Cancer Considered examines the treatment of EGFR-positive lung cancer in Brazil from early-stage disease to metastatic lung cancer.
Source: IASLCCategories: Hem/Onc News and Journals, Latest HeadlinesTweet
-
Mashup Score: 02023 Hot Topic in Basic & Translational Science: Resistance to IO in NSCLC | IASLC - 11 month(s) ago
The International Association for the Study of Lung Cancer (IASLC) is the only global network dedicated to the study and eradication of lung cancer and other thoracic malignancies.
Source: IASLCCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
We invite you to be a part of the groundbreaking #IO23 by submitting your abstract! Our conference focuses on the latest advancements & challenges in understanding & overcoming resistance to immune checkpoint inhibitors in #NSCLC. Submit Yours Today: https://t.co/OXVcckgrUB #LCSM https://t.co/DG1zM8aFAO
-
-
Mashup Score: 7Evolving Role of Liquid Biopsy for Lung Cancer | IASLC - 11 month(s) ago
In this episode of Lung Cancer Considered, host Dr. Stephen Liu leads a discussion with two global experts about the current and future roles of liquid biopsy a …
Source: IASLCCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
In this episode, host @StephenVLiu leads a discussion w/2 global experts about the current/future roles of liquid biopsy & its use for the treatment of #lungcancer: @ValsamoA from @JohnsHopkins, & @UmbertoMalapel1 from the University of Naples Federico II: https://t.co/C8OwytTIJB https://t.co/iqvuBzIGwb
-
-
Mashup Score: 0Evolving Role of Liquid Biopsy for Lung Cancer | IASLC - 11 month(s) ago
In this episode of Lung Cancer Considered, host Dr. Stephen Liu leads a discussion with two global experts about the current and future roles of liquid biopsy a …
Source: IASLCCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
In this episode, host @StephenVLiu leads a discussion w/2 global experts about the current/future roles of liquid biopsy & its use for the treatment of #lungcancer: @ValsamoA from @JohnsHopkins, & @UmbertoMalapel1 from the University of Naples Federico II: https://t.co/C8OwytTaU3 https://t.co/WvVOiQAMpi
-
-
Mashup Score: 0Seminal Trials - KEYNOTE 001 | IASLC - 11 month(s) ago
This new episode of Lung Cancer Considered features a discussion of the seminal trial KEYNOTE 001 and how it impacted research and clinical care for patients wi …
Source: IASLCCategories: Hem/Oncs, Latest HeadlinesTweet-
In this episode of #LungCancerConsidered, the official @IASLC podcast, we discussed the early development of pembrolizumab (Keytruda) as an immunotherapy agent for lung cancer in the KEYNOTE 001 trial with Dr. Eddie Garon and trial participant Cary Parton. https://t.co/ppd5ifCFEO
-
-
Mashup Score: 0Antibody Drug Conjugates (ADCs) in NSCLC | IASLC - 11 month(s) ago
What are Antibody Drug Conjugates, and do they have a promising future in lung cancer treatment? To discuss this topic, Lung Cancer Considered host Dr. Stephen …
Source: IASLCCategories: Hem/Oncs, Latest HeadlinesTweet-
For a discussion on antibody drug conjugates (ADCs) in NSCLC, take in this episode of #LungCancerConsidered, the official @IASLC podcast, where I discuss the class with Drs. @benlevylungdoc and @BeccaHeistMD. #LCSM https://t.co/qTMnbdwF9s
-
-
Mashup Score: 1Seminal Trials: IPASS for EGFR NSCLC | IASLC - 11 month(s) ago
In this special episode of Lung Cancer Considered, hosts Dr. Stephen Liu and Dr. Narjust Florez discuss the seminal IPASS trial with its principal investigator, …
Source: IASLCCategories: Hem/Oncs, Latest HeadlinesTweet-
As part of the Seminal Trials series, we talked with Dr. @TonyMok9 about the IPASS trial, building clinical research programs and the evolution of targeting #EGFR in NSCLC in this episode of #LungCancerConsidered, the official @IASLC podcast. #LCSM https://t.co/X1U9cEhBts
-
-
Mashup Score: 02023 Board of Directors Election Results | IASLC - 11 month(s) ago
The International Association for the Study of Lung Cancer (IASLC) is the only global network dedicated to the study and eradication of lung cancer and other thoracic malignancies.
Source: IASLCCategories: Hem/Oncs, Latest HeadlinesTweet-
Congratulations to the newly-elected @IASLC 2023 BOD Members. ➡️Kudos to the organization for creating a voting structure that guarantees female representation on the board. ➡️ But we still need more women, #LATAM & Africa representation. https://t.co/QVLVrK39d8 https://t.co/0d47OfLeBc
-
-
Mashup Score: 12Lung Cancer Considered | IASLC - 11 month(s) ago
The International Association for the Study of Lung Cancer (IASLC) is the only global network dedicated to the study and eradication of lung cancer and other thoracic malignancies.
Source: IASLCCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
Out of 3,118,367 podcasts, #LungCancerConsidered ranks in the top 5% globally! Congrats to hosts @NarjustFlorezMD & @StephenVLiu guests, & listeners of our podcast! Join your peers in listening here: https://t.co/vxO6I3rScX @DavidJamesGroup @IASLC #LCSM https://t.co/m7yq90JMcZ
-
-
Mashup Score: 8ASCO 2023 Highlights | IASLC - 11 month(s) ago
In this episode of Lung Cancer Considered, hosts Dr. Narjust Florez and Dr. Stephen Liu lead a discussion on the recently completed ASCO 2023 meeting that inclu …
Source: IASLCCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
Listen to #ASCO23 highlights on @IASLC #LungCancerConsidered w/hosts @NarjustFlorezMD & @StephenVLiu. Learn More on new OS data from the ADAURA trial & data from KEYNOTE 671 published in @nejmunofficial, w/Dr. Sarah Goldberg & @VamsiVelcheti: https://t.co/Ezc6PQVJAg #LCSM https://t.co/LfhIPMqJAT
-
#LungCancerConsidered host @NarjustFlorezMD examines treatment of EGFR-positive #lungcancer in Brazil, from early-stage disease to metastatic lung cancer. W/Dr. Juliana Ominelli (Brazilian National Cancer Institute) & @victormarcondes (Oncomed Oncologia): https://t.co/Fx7NhW5NEV https://t.co/q7pdgVtm3q